Like CCL5 and CXCL9, MDK is a profibrotic cytokine, demonstrated by its role in murine models of pulmonary fibrosis and its use as a biomarker in idiopathic pulmonary fibrosis (31). Here, CXCL9 is linked to pulmonary fibrosis.